• Event Times (GMT+10)
  • Local Times (GMT+2)
Data Blitz Session
Session Room 220
Wednesday, June 18, 10:50 AM – 12:05 PM
Data Blitz 8: Schizophrenia treatment
Successful Antipsychotic Dose Tapering Leading to Better Cognition in Patients with Remitted Psychosis: A 2-year Prospective Randomized-Controlled Trial
10:50 AM – 10:56 AM
6 min
Abnormalities of Subcortical Brain Volume throughout the Psychosis Course
10:56 AM – 11:02 AM
6 min
Clinical Practice Recommendations for Switching to Longer-Interval Injectable Antipsychotics in Schizophrenia Patients: A Modified Delphi Study in China
11:02 AM – 11:08 AM
6 min
Design of a phase 3, potentially pivotal, international, randomized, double-blind, placebo-controlled trial with evenamide, a glutamate modulator, add-on to SGA in patients with treatment-resistant schizophrenia
11:08 AM – 11:14 AM
6 min
Effects of Semaglutide on Body Weight in Clozapine-Treated Individuals with Schizophrenia and Obesity: A Randomized Controlled Trial
11:14 AM – 11:20 AM
6 min
Novel augmentation strategies for clozapine resistant schizophrenia: the role of adaptive platform trials
11:20 AM – 11:26 AM
6 min
The benefits of clozapine beyond its antipsychotic properties in treatment-resistant schizophrenia
11:26 AM – 11:32 AM
6 min
Impacts of Taiwan’s National Health Insurance Dedicated Budget Policy on Long-Acting Injectable Usage: An Interrupted Time-Series Analysis
11:32 AM – 11:38 AM
6 min
Exploring safe tapering of antipsychotics in patients with remitted psychosis: employing animal model and coadministration of N-Acetylcysteine study in bench and beside
11:38 AM – 11:44 AM
6 min
Discussion, Q&A
11:44 AM – 12:05 PM
21 min